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ABSTRACT
The prototypic protein disulfide isomerase (PDI), encoded by the
P4HB gene, has been described as a survival factor in ischemic
cardiomyopathy. However, the role of protein disulfide isomerase
associated 6 (PDIA6) under hypoxic conditions in the myocardium
remains enigmatic, and it is unknown whether the gut microbiota
influences the expression of PDI and PDIA6 under conditions of
acute myocardial infarction. Here, we revealed that, in addition to the
prototypic PDI, the PDI family member PDIA6, a regulator of
the unfolded protein response, is upregulated in the mouse
cardiomyocyte cell line HL-1 when cultured under hypoxia. In vivo,
in the left anterior descending artery (LAD) ligation mouse model
of acute myocardial infarction, similar to PDI, PDIA6 protein
expression was enhanced in the infarcted area (LAD+) relative to
uninfarcted sham tissue or the neighbouring area at risk (LAD–) of
C57BL/6J mice. Interestingly, we found that ex-germ-free (ex-GF)
mice subjected to the LAD ligation model for 24 h had a reduced
ejection fraction compared with their conventionally raised
(CONV-R) SPF controls. Furthermore, the LAD+ area in the
infarcted heart of ex-GF mice showed reduced PDIA6 expression
relative to CONV-R controls, suggesting that the presence of a gut
microbiota enhanced LAD ligation-triggered PDIA6 expression.
Collectively, our results demonstrate that PDIA6 is upregulated in
cardiomyocytes as a consequence of hypoxia. In the LAD mouse
model, PDIA6 was also increased in the infarcted area under in vivo
conditions, but this increase was suppressed in ex-GF mice relative
to CONV-R controls.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Acute myocardial infarction (AMI) triggers the unfolded protein
response (UPR) in cardiomyocytes to protect the ischemic
surrounding from hypoxic stress (Thuerauf et al., 2006; Wang
et al., 2018). The prototypic protein disulphide isomerase (PDI;
encoded by P4HB), the prototypic PDI family member ensuring
proper protein folding in the endoplasmic reticulum (ER), was
previously shown to protect from myocardial infarction (Toldo
et al., 2011a). However, there is an increase in P4HB levels with a
paradoxical decrease of its active form in the infarcted diabetic
mouse heart (Toldo et al., 2011b). PDI and other PDI family
members are instrumental to ensure correct protein folding and
to enhance superoxide dismutase 1 activity (Toldo et al., 2011a).
Adenoviral transfection and overexpression of PDI in the mouse
myocardium was shown to attenuate cardiac remodelling and to
diminish cardiomyocyte apoptosis (Toldo et al., 2011a). Inside the
vasculature, the oxidoreductase function of PDI is critical for
the activation of cryptic blood-borne tissue factor on monocytes,
the coagulation initiator that promotes arterial thrombus formation
(Reinhardt et al., 2008). Furthermore, the oxidoreductase PDI
regulates fibrin-mediated platelet aggregation (Lahav et al., 2002).
PDI expression was also elevated in the myocardium of mice that
were exposed to systemic hypoxia and in infarcted heart tissue (Tian
et al., 2009). In addition to cardiomyocytes, the expression of PDI,
which protects from apoptosis and promotes cell migration and
adhesion, is also induced in endothelial cells (Tian et al., 2009).
Hence, it is relevant to explore whether other PDI family members
that are involved in the setting of AMI, are induced in
cardiomyocytes.
In mammalian cells, three distinct pathways regulate the UPR: ER
transmembrane inositol-requiring enzyme 1α (IRE1α), pancreatic
ER kinase (PERK) and activating transcription factor 6 (ATF6).
Hypoxia is a well-recognised activator of the UPR in cardiac
myocytes (Thuerauf et al., 2006). The PDI family member PDIA6
(ERP5, TXNDC7) is an ER-resident protein that plays a crucial
role in ER stress, as it limits the activation of the UPR by blocking
the activity of the UPR sensor IRE1α through its direct binding
to cysteine 148 and also acts on PERK (Eletto et al., 2014).
An additional pool of PDIA6 acts as a cofactor of binding
immunoglobulin protein (BiP; GRP-78), an ER resident chaperone
(Jessop et al., 2009). Interestingly, the loss of PDIA6 does not result
in ER stress and impaired protein folding (Rutkevich et al., 2010),
but, vice versa, it has been demonstrated with neonatal rat
ventricular myocytes that the PDIA6 underlies regulation by
ATF6, which is activated by hypoxia, and that adenoviral
overexpression of PDIA6 protects cardiomyocytes from
stimulated ischemia/reperfusion-induced cell death (Vekich et al.,
2012; Doroudgar et al., 2009).Received 28 September 2018; Accepted 13 November 2018
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Interestingly, recent research has revealed that impairment of the
ER stress response in the gut epithelium is linked to intestinal
dysbiosis and inflammation (Coleman et al., 2018; Kaser et al.,
2008; Adolph et al., 2013), but it is currently unresolved whether the
absence of a gut microbiota can impact the UPR in the intestine and
whether hypoxia-regulated elements of the UPR are influenced
by microbial colonisation at remote vascular sites, such as the
myocardium. As an improved ER protein-folding capacity supports
cardiomyocyte survival and PDIA6 plays a protective role by
limiting the UPR, it is crucial to understand the conditions that
determine hypoxia-induced PDIA6 expression in cardiomyocytes.
Because the influence of hypoxia on PDIA6, as it occurs during
AMI, is unexplored, we here studied the impact of hypoxia (1%
oxygen) on the expression of PDIA6 in HL-1 cardiomyocytes. To
elucidate whether this UPR-regulator is influenced at the site of
infarction in vivo, we analysed PDIA6 expression in a mouse model
of AMI. Our results revealed that PDIA6 is upregulated in hypoxia-
treated cardiomyocytes and in the infarcted cardiac tissue of
mice subjected to left anterior descending artery (LAD) ligation. By
analysing germ-free (GF) mice that were subjected to LAD ligation,
we observed that the increase in PDIA6 expression in the murine
myocardiumwas significantly reduced when the gut microbiota was
absent, providing first evidence that the colonisation status of the
host may impact the UPR in the infarcted myocardium.
RESULTS
Hypoxia increases the expression of PDIA6 in cultured HL-1
cardiomyocytes
Since PDIA6 has been suggested to be part of the ER stress response
in cardiomyocytes, we used a hypoxic chamber to apply 1%
hypoxia for 12 h and 24 h to cultured HL-1 cells (Claycomb et al.,
1998). We confirmed the hypoxic conditions by the expected
upregulation of hypoxia-inducible factor-1-α (HIF1α) after 24 h of
incubation (Fig. 1A), which escapes degradation due to the absence
of PHD-mediated hydroxylation under hypoxic conditions (Fig. S1)
(Hölscher et al., 2011; Myllyharju, 2008). Strikingly, in addition
to PDI (P4HB), our experiments comparing hypoxic HL-1
cardiomyocytes revealed that the protein levels of PDIA6 are
likewise increased during hypoxia after 12 h (Fig. 1B,C). In
contrast, at 24 h of incubation, only a tendency of increased PDIA6
expression was detected (data not shown). Of note, this increase in
PDIA6 protein levels was not detected in human umbilical vein
endothelial cells (HUVECs) (Fig. S2). Therefore, our results
demonstrate that PDIA6, which was previously identified as a
negative regulator of the UPR (Eletto et al., 2014), is increased by
hypoxia in cultured cardiomyocytes.
Expression of PDIA6 is enhanced in the infarcted mouse
myocardium
We next interrogated whether PDIA6 protein levels are also
upregulated in the infarcted tissue area, applying the LAD ligation
mouse model of AMI. Infarction was confirmed by ultrasound
imaging, indicated by a significant reduction of the left ventricular
ejection fraction 24 h post-LAD ligation (Fig. 2A). This model
causes hypoxic conditions in the infarcted area (LAD+), since
hypoxia-regulated gene expression is elevated relative to sham
tissue or the neighbouring area at risk (LAD−), as confirmed by
elevated PHD3 expression levels (Fig. 2B) (Hirsilä et al., 2003;
Rohrbach et al., 2005). Similar to the established role of PDI
(P4HB) (Toldo et al., 2011a), the UPR regulator PDIA6 was
increased in the infarcted LAD+ area relative to the LAD− area or
tissues taken from the same site of sham-operated mice (Fig. 2C). In
accordance, PDI showed enhanced protein levels in the LAD+ and
LAD− area relative to the tissues of sham-operated mice (Fig. 2D).
This increase was further reflected by increased plasma PDI levels
(Fig. 2E). Interestingly, PDIA6 protein levels were threefold
increased in the LAD+ area relative to specimens from sham-
treated mice, and PDIA6 was significantly increased in the LAD+
area compared to the LAD− area (Fig. 2F). The increase of PDI
and PDIA6 in the infarcted myocardium was further corroborated
by immunohistochemistry of LAD+ specimens relative to sham-
operated control tissue (Fig. 2G). In line with PDI, our results
indicate that the hypoxia-dependent increase of PDIA6 found in
HL-1 cardiomyocytes can be translated to the experimental
conditions of AMI, where the arterial supply of oxygen is ceased
in the infarcted LAD+ area.
Fig. 1. Hypoxia-induced upregulation of HIF1α, PDI and PDIA6 in HL-1 cardiomyocytic cells. (A) Hypoxia-dependent (1% O2) increase in HIF1α protein
expression relative to β-actin (n=3, 24 h incubation). (B,C) Hypoxia-dependent (1% O2) increase in PDI (n=4, 24 h incubation) (B) and PDIA6 (n=3, 12 h
incubation) (C) protein levels relative to α-actinin. Normoxia, black bars; hypoxia, grey bars. All data are expressed as mean±s.e.m. Statistical comparisons
were performed using the Student’s t-test; *P<0.05, ****P<0.0001.
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Fig. 2. The expression of PDI and PDIA6 is
increased in the infarcted area (LAD+) in the 24 h
LAD ligation mouse model. (A) Long axis (n=6,9)
and short axis (n=6,8) of the left ventricle after LAD
ligation; SPF C57BL/6J mouse. (B) mRNA expression
of the myocardial hypoxia marker PHD3 is increased
relative to L32 in the LAD+ area compared with sham
or LAD– tissues (n=4,5,5). (C) PDI and PDIA6 mRNA
expression relative to L32 is increased in the LAD+
area compared with sham or LAD– tissues (n=5).
(D,E) PDI protein levels are increased relative to
α-actinin in the LAD+ (n=6) and LAD– (n=6) tissues
compared to sham-operated heart tissue (n=5)
(western blot) (D) and in plasma (n=6,8) (ELISA) (E).
(F) PDIA6 protein levels are increased in LAD+ heart
tissue relative to sham or LAD– tissues (ELISA) (n=5).
(G) Immunohistochemistry for PDI (top row) and PDIA6
(bottom row) in sham-operated and infarcted LAD+
heart tissue (representative micrographs). Scale bars:
100 µm. LAD+ represents the ligated areas, LAD–
represents the area proximal to ligation and sham
represents the sham-operated animals. All data are
expressed as mean±s.e.m. Statistical comparisons
were performed using the Student’s t-test and one-way
ANOVA; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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The gut microbiota determines the reduction in the ejection
fraction and PDIA6 expression levels of the infarcted mouse
heart
As there is increasing evidence for the gut microbiota as a
determinant of myocardial infarction (Lam et al., 2012), and
because we found that the presence of a gut microbiota enhances
angiotensin II-induced cardiac fibrosis (Karbach et al., 2016), we
took advantage of the GF mouse model to explore whether the host
colonisation status impacts on ventricular function and myocardial
PDI expression under ischemic conditions in the LAD ligation
model. Effective myocardial infarction was induced by LAD ligation
in the GF mice, as demonstrated by ultrasound imaging of the left
ventricle (Fig. 3A). Interestingly, the sham-operated ex-GF mice
had a significantly reduced ejection fraction as compared to
conventionally raised (CONV-R) controls (Fig. 3B). Intriguingly,
we found a pronounced decrease of the ejection fraction in LAD-
ligated ex-GFmice after we normalised to sham-operated ex-GFmice
as compared to the normalised LAD-ligated CONV-R mice
(Fig. 3C). As expected, also in the ex-GF mice, PDI and PDIA6
mRNA expression levels were increased in the LAD+ area relative to
the LAD− area or sham-operated tissues of ex-GF mice that lack
colonisation with a gut microbiota (Fig. 3D). In the left ventricle, PDI
and PDIA6 transcript levels were unchanged under basal conditions,
comparing sham-operated CONV-R and ex-GF mice (Fig. 3E). Most
interestingly, when we compared the PDIA6 transcript levels in the
LAD+ area of ex-GF mice with those of CONV-R mice, we noted
significantly reduced PDIA6 expression in response to LAD ligation
(Fig. 3F). This is in contrast to the transcript levels of PDI, whichwere
unchanged in the LAD+ area between ex-GF and CONV-R mice
(Fig. 3F). Hence, our results imply that the presence of a gut
microbiota, which acts as a chronic inflammatory stimulus, can affect
the LAD-ligation-induced UPR in the mouse myocardium.
DISCUSSION
Our results show a direct upregulation of PDIA6 in cardiomyocytes
due to hypoxic culture conditions. The in vivo relevance of
increased PDIA6 in cardiomyocytes, an established regulator of the
UPR, was further demonstrated under conditions of AMI in the
murine model of myocardial infarction (permanent LAD ligation).
Intriguingly, we found that the LAD-ligation-induced upregulation
of PDIA6 was significantly reduced in the LAD+ area of ex-GF
mice relative to their conventionally raised counterparts, providing
first evidence that the UPR of the infarcted heart may be influenced
by the colonisation status of the host.
Fig. 3. 24 h LAD ligation model of acute myocardial infarction in germ-free mice. (A) Long axis (n=6,9) and short axis (n=6,8) of the left ventricle after
LAD ligation of ex-germ-free (ex-GF) C57BL/6J mice as determined by ultrasound imaging. (B) Ejection fraction % of the long (n=6,3) and short axis (n=6,3)
of sham-operated C57BL/6J mice kept under SPF conventionally raised (CONV-R) or ex-GF conditions. (C) Comparison of the long axis (n=9,9) and the
short axis (n=8,8) of CONV-R SPF C57BL/6J mice, with ex-GF C57BL/6J mice normalised to sham-operated controls. (D) PDI (n=6,4,6) and PDIA6
(n=6,6,6) mRNA expression in sham-operated, LAD+ and LAD– heart tissues of ex-GF mice. (E) PDI and PDIA6 mRNA expression in heart tissues of sham-
operated ex-GF mice compared to SPF CONV-R mice (n=6,3). (F) PDI (n=6) and PDIA6 (n=5) mRNA expression in LAD+ heart tissues of ex-GF mice
compared to SPF CONVR mice. LAD+ represents the ligated area, LAD– represents the area proximal to ligation and sham represents the sham-operated
animals. All data are expressed as mean±s.e.m. Statistical comparisons were performed using the Student’s t-test or one-way ANOVA; n.s., not significant;
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
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In contrast to previous studies that identified PDIA6 in isolated rat
cardiac myocytes, demonstrating the regulation via ATF6 and as an
integral part of the ER stress response (Vekich et al., 2012; Eletto
et al., 2014), we could, for the first time, demonstrate that hypoxia
(1% oxygen) induced increased expression of this UPR-regulating
factor in the HL-1 cardiomyocyte cell line. This finding is in line
with the hypoxia-dependent upregulation of PDIA6 reported in a
human cervix cancer cell line (SiHa) and a human head and neck
cancer cell line (FaDuDD) (Sørensen et al., 2009). This indicates that
the hypoxia-dependent upregulation of PDIA6 is not restricted to
cardiac myocytes. Remarkably, because hypoxia-induced ATF6
upregulation protects rats from ischemia/reperfusion-induced
necrosis (Jia et al., 2016), and PDIA6 is induced by ATF6 in
ischemia/reperfusion and has a protective role in cardiomyocytes
(Vekich et al., 2012), our results with HL-1 cells cultured at 1%
oxygen atmosphere in a hypoxic chamber imply that PDIA6
mediates part of this protective hypoxia-dependent effect.
Hypoxia evokes the UPR in the ER, as shown in ventricular
myocyte cultures (Thuerauf et al., 2006). To explore whether PDIA6
is a relevant hypoxia-regulated factor during AMI, we have tested
the in vivo relevance of the identified hypoxia-induced PDIA6
upregulation, which is specific to cardiomyocytes in themousemodel
of myocardial infarction by permanent LAD ligation, showing a vast
increase in PDIA6 protein expression in the infarcted LAD+ area, but
not in the LAD− area (area at risk). This is in contrast to prototypic
PDI, which was also increased in the LAD− area. In a seminal study
with adenoviral constructs that either increased or suppressed PDIA6
expression, it has been convincingly demonstrated that PDIA6
protects neonatal rat ventricular myocytes from stimulated ischemia/
reperfusion-induced cell death (Vekich et al., 2012). Furthermore,
previous molecular biological studies have revealed that hypoxia-
dependent ATF6 promotes PDIA6 expression (Vekich et al., 2012)
and that PDIA6 controls the attenuation of IRE1 and PERK signals,
but does not impact on ATF6 signalling (Eletto et al., 2014). Thus,
our result on the upregulation of PDIA6 in infarcted heart tissue is
coherent with the established role of PDIA6 in attenuating the
hypoxia-induced UPR that was identified in cell culture models.
The gut microbial ecosystem influences vascular physiology and
there is emerging evidence for the implication of the gut microbiota
as a determinant of the extent of myocardial infarction (Reinhardt
et al., 2012; Lam et al., 2012, 2016). In previous work, we have
identified that the colonisation status of the host affects angiotensin
II-triggered cardiac fibrosis and tissue infiltration with myeloid cells
(Karbach et al., 2016). Therefore, we applied the LAD ligation
model to ex-GF mice to study the extent of the functional
impairment of ventricular function in gnotobiotic mice, and to test
whether the expression of UPR regulator PDIA6 is influenced by
the absence of the gut microbiota. With ex-GF mice, we revealed
that, in the absence of the gut microbiota, the LAD-ligation-induced
increase in PDIA6, which suppresses the UPR in the ER, is severely
perturbed. This was associated with an increased drop of the
ejection fraction in ex-GF mice relative to CONV-R controls at 24 h
of LAD-ligation-induced myocardial infarction. Of note, there is
still no remodelling at this early time point. As the upregulation of
PDIA6 protects neonatal rat ventricular cardiomyocytes from
simulated ischemia/reoxygenation-induced cell death (Vekich
et al., 2012), it is conceivable that the impaired cardiovascular
function following LAD ligation in the ex-GF mouse model relative
to CONV-R controls is due to the reduced upregulation of PDIA6 as
part of the myocardial UPR.
Additional work with gnotobiotic mouse models is required to
define the role of colonizing microbial communities in myeloid cell
infiltration and cardiac remodelling during AMI. As the loss of
PDIA6 does not result in significant ER stress and impaired protein
folding (Rutkevich et al., 2010), it will be important to target PDIA6
in an in vivo mouse model of AMI to explore how this hypoxia-
induced UPR regulator affects infarct size. Future studies should
also delineate the exact pathways of the ER stress response that are
regulated by the deficiency or increased activity of PDIA6 in AMI.
MATERIALS AND METHODS
Animals
C57BL/6Jmicewere 8- to 14-week-oldmale mice housed in the Translational
Animal Research Center (TARC) of the University Medical Center Mainz
under specific-pathogen-free (SPF) or GF conditions in EU type II cages, with
two to five cage companions, standard autoclaved laboratory diet and water ad
libitum, 22±2°C room temperature and a 12 h light/dark cycle. GF mice were
maintained as a GF mouse colony in sterile flexible film mouse isolator
systems. The GF status of mice was tested weekly by polymerase chain
reaction (PCR) for detection of 16S rDNA and by bacterial culture. GF mice,
named as ex-GF, were kept under standard SPF conditions following LAD
ligation for 24 h. All groups of mice were age and weight matched and were
free of clinical symptoms. All procedures performed on mice were
approved by the local committee on legislation on protection of animals
(Landesuntersuchungsamt Rheinland-Pfalz, Koblenz, Germany; G10-1-051).
Cell culture
The HL-1 cell line, derivatives from the AT-1 mouse atrial cardiomyocyte
tumour lineage (Claycomb et al., 1998), was maintained in Claycomb
medium (Sigma-Aldrich, St. Louis, MI, USA) supplemented with 0.1 mM
Norepineprin, 2 mM L-glutamine, 100 U/ml penicillin/streptomycin and
10% v/v fetal bovine serum. Cells were seeded in six-well plates, coated
overnight with 0.02% w/v gelatin and 0.5% v/v fibronectin. Upon 80%
confluency or more, cells were placed in the hypoxic chamber adjusted at
1% O2 and 5% CO2, at 37°C (Coy Laboratory Products, Grass Lake, MI,
USA), washed and supplemented with hypoxic Claycomb medium, and
then incubated for 12 h or 24 h in hypoxia or normoxia. After the desired
time point, cells were washed and lysed for RNA or protein extraction.
LAD ligation
Male mice (8 to 12 weeks old) underwent either permanent LAD ligation
injury or sham operation. Mice were anaesthetised through intraperitoneal
injection of midazolam [5 mg/kg body weight (BW)], medetomidine
(0.5 mg/kg BW) and fentanyl (0.05 mg/kg BW). During surgery, mice were
mechanically ventilated using a rodent ventilator. Ischaemia injury was
induced by permanent occlusion of the LAD artery with an 8-0 prelene
suture (Johnson & JohnsonMedical, Norderstedt, Germany). The ischaemic
area below ligation was reassured by visual examination of a bright colour in
the occluded myocardium. Atipamezol (0.05 mg/kg BW) and flumazenil
(0.01 ml/kg BW) were administered to the mice for analgesia after
operation. Sham mice underwent the same operation procedure except
coronary artery ligation. Mice were sacrificed 24 h after ligation by
exsanguination in isoflurane anaesthesia.
Ultrasound imaging
Micewere anaesthetised with isoflurane, and heart rate and temperaturewere
monitored during examination. High-frequency ultrasound was performed
by a Vevo 770 system (FUJIFILM, VisualSonics, Toronto, Canada)
represented as ejection fraction (%). Images were obtained from the left
parasternal long axis and short axis. In two-dimensional guided m-mode
(2D), various parameters including left ventricular end-diastolic diameter
(LVEDD) and left ventricular end-systolic diameter (LVESD) were
measured in accordance with the American Society of Echocardiography.
Preparation of protein extracts from cells or tissues
Samples were mechanically lysed in cell lysis buffer (50 mM Tris-HCl,
150 mMNaCl, 5 mM EDTA, 1% Triton X-100, pH 8) containing complete
protease inhibitor cocktail tablets (Roche, Penzberg, Germany), passing
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through a 30G×1/2″ needle at least five times. The homogenates were
incubated for 30 min on ice and centrifuged three times at 9000 g for 10 min
at 4°C to remove insoluble debris. Tissues were homogenised in cell lysis
buffer by the Tissue Lyser II (Qiagen, Hilden, Germany) for 5 min at 30 Hz.
They were then kept on ice for 30 min and centrifuged three times at 9000 g
for 10 min at 4°C to remove insoluble debris. Protein concentrations for cells
and tissues were quantified using a DC Protein Assay Kit 2 (Bio-Rad,
Hercules, CA, USA) according to the manufacturer’s instructions.
Western blot
Protein lysates were supplemented with 3× sample loading buffer [62.5mM
Tris-HCl pH 6.8, 2.5% w/v sodium dodecyl sulfate (SDS), 0.002% w/v
Bromophenol Blue, 5% v/v β-mercaptoethanol, 10% v/v glycerol] and the
proteins were denaturated for 10 min at 99°C. Thirty microliters of the
denaturated proteins were subjected to 8% SDS-polyacrylamide gel
electrophoresis and were then transferred onto a nitrocellulose membrane.
Unspecific binding was blocked with 5% bovine serum albumin in Tris-
buffered saline (TBS) supplemented with Tween 20 (20 mM Tris-base,
137 mMNaCl, 0.05% v/v Tween 20) for 30 min, and the primary antibodies
anti-HIF-1-alpha, anti-PDI EPR9498, anti-PDIA6 EPR11132 (Abcam,
Cambridge, UK), anti-β-actin and anti-α-actinin (Cell Signaling
Technology, Danvers, MA, USA) were incubated overnight at 4°C and
1:1000 dilution, with gentle agitation. The membrane was washed for 1 h
with TBST buffer (150 mMNaCl, 7.7 mM Tris-HCl pH 7.5, 1% Tween 20)
and the secondary antibody peroxidase anti-rabbit IgG (H+L) at 1:10.000
dilution (Vector Laboratories, Burlingame, CA, USA) was incubated for
1 h. The membrane was washed for 1 h with TBST buffer and incubated in
luminol chemiluminescent substrate (Cell Signaling Technology) for 1 min.
The membranes were developed by a Chemi Doc Touch imaging system
(Bio-Rad) and the densitometry analysis was performed by using ImageJ
software (https://imagej.nih.gov/ij/).
Quantitative real-time PCR
Total RNA was isolated from the cells with the RNeasy Kit and from the
tissues with the RNeasy Fibrous Tissue Mini Kit (Qiagen) according to the
manufacturer’s instructions. Total RNA (2 μg) was reverse transcribed with
a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, USA), and SYBR green-based quantitative real-time PCR
was performed with iQ SYBR Green Supermix (Bio-Rad). The
oligonucleotide sequences used are listed in Table S1.
Mouse PDI (P4HB) and PDIA6 ELISA
Enzyme-linked immunosorbent assays (ELISAs) for both PDI and PDIA6were
performed according to the manufacturer’s instructions (MyBioSource.com,
San Diego, CA, USA).
Immunohistochemistry
Tissues were fixed in Roti®-Histofix 4% (Carl Roth, Karlsruhe, Germany)
and provided to the Core Facility Histology of the University Medical
Center Mainz for PDI with anti-P4Hb antibody (Abcam) and for PDIA6
(Aviva Systems Biology, San Diego, CA, USA) staining. All sections were
analysed by light microscopy (Axia Lab.A1, Zeiss, Oberkochen, Germany).
Statistical analysis
All values are expressed as mean±s.e.m. Data sets were analysed with Prism
6 (GraphPad Software, San Diego, CA, USA) using one-way analysis of
variance (ANOVA) or unpaired Student’s t-tests. Differences of P<0.05
were considered statistically significant.
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Alsner, J. (2009). Proteins upregulated by mild and severe hypoxia in
squamous cell carcinomas in vitro identified by proteomics. Radiother. Oncol.
92, 443-449.
Thuerauf, D. J., Marcinko, M., Gude, N., Rubio, M., Sussman, M. A. and
Glembotski, C. C. (2006). Activation of the unfolded protein response in
infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ. Res. 99,
275-282.
Tian, F., Zhou, X., Wikström, J., Karlsson, H., Sjöland, H., Gan, L.-M., Borén, J.
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